Reuters: Regulatory News: Medtronic gets European nod for Viva/Brava heart device

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

Medtronic gets European nod for Viva/Brava heart device Aug 20th 2012, 22:21 Mon Aug 20, 2012 6:21pm EDT Aug 20 (Reuters) - Medtronic Inc said it received European approval for its Viva/Brava portfolio of devices that is used on heart failure patients. The world's largest maker of medical devices said the products feature a new algorithm, called AdaptivCRTR, that maintains the patients' normal heart rhythms. Shares of the Minneapolis-based company closed at $41.45 on New York Stock Exchange on Monday.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions